Co-design of an AI Rehabilitation Program for Children With Borderline Intellectual Disorder
28 maj 2026 uppdaterad av: Jeong Yi Kwon, Samsung Medical Center
Multidisciplinary Experience-Based Collaborative Design (Co-design) Study of a Tablet-Based AI Cognitive and Language Rehabilitation Program for School-Aged Children With Borderline Intellectual Disorder
Co-design of an AI Rehabilitation Program for Children With Borderline Intellectual Disorder
Studieöversikt
Status
Aktiv, inte rekryterande
Intervention / Behandling
Detaljerad beskrivning
This study aims to co-design a tablet-based artificial intelligence (AI) cognitive and language rehabilitation program for school-aged children with borderline intellectual disorder using an experience-based collaborative design (EBCD) approach.
Children with prior experience using the program, their legal guardians, and relevant professionals will participate in interviews and collaborative workshops to identify user needs and improve program usability.
Studietyp
Observationell
Inskrivning (Beräknad)
30
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Seoul
-
Seoul, Seoul, Sydkorea, 06351
- Samsung Medical Center
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Testmetod
Icke-sannolikhetsprov
Studera befolkning
The study population includes school-aged children with borderline intellectual disorder who have prior experience using a tablet-based AI cognitive and language rehabilitation program, their legal guardians, and professionals involved in the development or clinical application of rehabilitation programs for children with borderline intellectual disorder.
Beskrivning
Inclusion Criteria:
- School-aged children aged 7 to under 16 years with borderline intellectual disorder who have experienced the tablet-based AI cognitive and language rehabilitation program at least once
- Legal guardians of eligible children
- Developers of the AI rehabilitation program or professionals with expertise in cognition, language, learning, or rehabilitation for children with borderline intellectual disorder
Exclusion Criteria:
- Individuals who are unable to participate in interviews or workshops due to communication difficulties or inability to provide informed consent/assent
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Children With Borderline Intellectual Disorder
School-aged children aged 7 to under 16 years with borderline intellectual disorder who have experienced the tablet-based AI cognitive and language rehabilitation program at least once.
|
A tablet-based artificial intelligence (AI) cognitive and language rehabilitation program previously experienced by children with borderline intellectual disorder.
The study collects user and provider experiences through interviews and collaborative workshops to support experience-based co-design and program improvement.
|
|
Legal Guardians
Legal guardians of children with borderline intellectual disorder who have experienced the tablet-based AI cognitive and language rehabilitation program.
|
|
|
Developers and Professionals
Developers of the AI rehabilitation program and professionals with clinical expertise in cognition, language, learning, or rehabilitation for children with borderline intellectual disorder.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Qualitative Themes Regarding Participant Experiences with the AI Rehabilitation Program
Tidsram: Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).
|
Qualitative themes regarding participant experiences with the tablet-based AI cognitive and language rehabilitation program will be identified.
In-depth interviews will be conducted with users with borderline intellectual functioning and their legal guardians to explore usability and satisfaction.
Additionally, focus group discussions with developers and clinical professionals will be held to gather multidisciplinary insights.
All qualitative data will be analyzed using qualitative content analysis to extract key core themes.
Therefore, there is no quantitative scale used.
Results will be reported as identified thematic categories.
|
Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Perceived Barriers and Challenges to AI Rehabilitation Program Use
Tidsram: Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).
|
Participant-perceived barriers and challenges related to the use of the tablet-based AI cognitive and language rehabilitation program will be identified.
Through semi-structured qualitative interviews with users with borderline intellectual functioning and their legal guardians, as well as focus group discussions with developers and clinical professionals, potential obstacles to program adherence, technical difficulties, and clinical limitations will be explored.
All qualitative data will be analyzed using thematic analysis to extract core barrier themes.
Therefore, there is no quantitative scale used.
Results will be reported as identified thematic categories.
|
Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).
|
|
Co-design Recommendations for AI Rehabilitation Program Improvement
Tidsram: Once per participant/professional during the co-design workshop sessions conducted during the study period (overall data collection through December 2026).
|
Recommendations for the improvement and optimization of the tablet-based AI cognitive and language rehabilitation program will be developed.
Through collaborative co-design workshops involving users with borderline intellectual functioning, their legal guardians, developers, and clinical professionals, actionable insights regarding feature enhancements and interface modifications will be explored.
All qualitative data gathered from the workshops will be analyzed using thematic analysis to synthesize core design recommendations.
Therefore, there is no quantitative scale used.
Results will be reported as identified thematic categories and recommendation frameworks.
|
Once per participant/professional during the co-design workshop sessions conducted during the study period (overall data collection through December 2026).
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
24 april 2026
Primärt slutförande (Beräknad)
31 december 2026
Avslutad studie (Beräknad)
31 december 2026
Studieregistreringsdatum
Först inskickad
12 maj 2026
Först inskickad som uppfyllde QC-kriterierna
28 maj 2026
Första postat (Faktisk)
4 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
4 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
28 maj 2026
Senast verifierad
1 maj 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2025-12-062
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
OBESLUTSAM
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .